Mental Health Technologies Co (TSE:9218) Research & Development: 円0 Mil (TTM As of Dec. 2025)


TSE:9218 Mental Health Technologies Co Ltd TSE:9218
72 GF Score
Price 円735.00
GF Value 円2,284.08
Valuation Significantly Undervalued
! 5 Warning Signs
View Full Analysis

What is Mental Health Technologies Co Research & Development?

Mental Health Technologies Co TSE:9218 +1.10% 72 Research & Development is 円0 Mil as of Dec. 2025. GuruFocus rates TSE:9218 with a GF Score™ of 72/100 and a GF Value™ of 円2,284.08 (Significantly Undervalued). The stock has 5 warning signs investors should review.

Research & Development is the aggregate amount of research and development expenses during the year. Mental Health Technologies Co's Research & Development for the three months ended in Dec. 2025 was 円0 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Dec. 2025 was 円0 Mil.

Mental Health Technologies Co  (TSE:9218) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

Mental Health Technologies Co Research & Development Related Terms

Mental Health Technologies Co Research & Development Historical Data

* Premium members only.

The historical data trend for Mental Health Technologies Co's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Mental Health Technologies Co Research & Development Chart

Mental Health Technologies Co Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Research & Development
Get a 7-Day Free Trial 0.00 0.00 0.00 0.00 0.00

Mental Health Technologies Co Quarterly Data
Dec19 Dec20 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
TSE:9218
72GF Score
Mental Health Technologies Co Ltd TSE:9218
Research & Development is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Mental Health Technologies Co Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Dec. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was 円0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Research & Development →
What does a Research & Development of 円0 Mil mean?
Mental Health Technologies Co (TSE:9218) has a Research & Development of 円0 Mil as of Dec. 2025. Research and development expense is the total cost for research and development activities. View historical data on Mental Health Technologies Co and its competitors.
Is Mental Health Technologies Co's Research & Development too high?
Mental Health Technologies Co's current Research & Development is 円0 Mil. Overall, Mental Health Technologies Co has a GF Score™ of 72/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Mental Health Technologies Co's Research & Development compare to HCA and THC?
Mental Health Technologies Co's Research & Development of 円0 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Research & Development for a Healthcare Providers & Services company?
A good Research & Development depends on the Healthcare Providers & Services industry context. However, Research & Development should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Research & Development mean?
A high Research & Development can signal that a stock is expensive relative to its fundamentals. Research and development expense is the total cost for research and development activities. View historical data on Mental Health Technologies Co and its competitors. Mental Health Technologies Co's current Research & Development is 円0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Mental Health Technologies Co stock overvalued right now?
Based on GuruFocus' analysis, Mental Health Technologies Co (TSE:9218) is currently considered Significantly Undervalued. The stock's GF Value™ is 円2,284.08, compared to a current price of 円735.00 — trading 67.8% below its estimated fair value. The current Research & Development is 円0 Mil. Mental Health Technologies Co's overall GF Score™ is 72/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Research & Development calculated?
Research & Development is calculated from a company's financial statements. For Mental Health Technologies Co (TSE:9218), the current Research & Development is 円0 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Mental Health Technologies Co (TSE:9218) Overvalued in 2026?

Based on GuruFocus' analysis, Mental Health Technologies Co stock appears to be undervalued. The current stock price of 円735.00 is trading 67.8% below its estimated GF Value™ of 円2,284.08. GuruFocus considers Mental Health Technologies Co to be Significantly Undervalued.

Key valuation signals for TSE:9218:

  • Research & Development: 円0 Mil
  • GF Value™: 円2,284.08 vs. price of 円735.00 (67.8% below fair value)
  • GF Score™: 72/100 with 5 warning signs

No single metric tells the full story. See the TSE:9218 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Mental Health Technologies Co Business Description

Address 3-16-11 Akasaka, 4th Floor, Tokai Akasaka Building, Minato-ku, Tokyo, JPN, 107-0052
Mental Health Technologies Co Ltd is mainly engaged in providing mental health solutions. Along with its subsidiaries, the company operates in the following reportable segments: Mental Health Solutions Business, Medical Work Shift Business, Medical Career Support Business, and the Digital Marketing Business. The majority of its revenue is generated from the Mental Health Solutions Business, which provides services by industrial physicians and public health nurses, and manages the mental and physical health of workers. It has packaged the various mental health care services under ELPIS, a cloud service, and offers it to its clients under the name Occupational Physician Cloud.
72GF Score

Get the complete analysis for TSE:9218

Research & Development is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

円735.00
Price
円2,284.08
GF Value